Infusion RCM: Why February is a Critical Inflection Point for Prior Auth & Intake
Why is February a critical inflection point for infusion providers? Learn how to identify prior auth risks and stop Q1 revenue leakage before denials escalate.
Why is February a critical inflection point for infusion providers? Learn how to identify prior auth risks and stop Q1 revenue leakage before denials escalate.
Why is February a critical inflection point for infusion providers? Learn how to identify prior auth risks and stop Q1 revenue leakage before denials escalate.
Learn how analyzing denial trends and building a structured feedback loop can drive systemic RCM improvement and faster claim resolution.
A nationwide specialty pharmacy provider headquartered in Morrisville, North Carolina delivers high-dollar infusion therapies, including IGG drugs, to patients across most U.S. states.
Prochant Appoints Ronda Buhrmester as Vice President of Client Experience to Deepen Client Partnerships
Maximize revenue recovery by working the right denials first. Learn how AI-driven prioritization and guided resolution help RCM teams reduce A/R days and write-offs.
As 2026 approaches, RCM is no longer just a back-office function. It’s becoming a defining factor in whether pharmacies can scale, adapt and protect revenue in a high-stakes environment.